Form 4: Aspen Aerogels Director Equity Grant Disclosure

Director William P. Noglows received an annual equity grant of restricted stock units and stock options as part of Aspen Aerogels' non-employee director compensation policy.

Summary

• Director William P. Noglows was granted 10,370 Restricted Stock Units (RSUs) on May 13, 2026.
• Director Noglows was granted 8,706 stock options with an exercise price of $5.40 on May 13, 2026.
• The equity awards vest on the earlier of May 13, 2027, or the day prior to the 2027 annual meeting of stockholders.
• Following the transaction, the director holds 99,357 shares directly and 20,000 shares indirectly through family trusts.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral, routine administrative filing regarding director compensation that does not signal a change in company strategy or financial health.

Positives

• Alignment of director interests with long-term shareholder value through equity-based compensation.
• Standardized compensation practice consistent with the company's non-employee director policy.

Negatives

• Dilutive impact of new equity grants on existing shareholders, though standard for corporate governance.

Risks

• Market volatility affecting the value of the granted stock options and RSUs.
• Potential for future dilution if additional equity grants are issued to directors and employees.

Future Outlook

The equity awards are subject to vesting on May 13, 2027, or the day prior to the 2027 annual meeting, whichever occurs first.

Management Comments

• The grants are issued pursuant to the Issuer's Non-Employee Director Compensation Policy.

Industry Context

StockSavvy.ai notes that this filing represents routine corporate governance activity. Equity-based compensation for board members is a standard industry practice to ensure director retention and alignment with shareholder interests in the advanced materials and manufacturing sectors.

Comparison to Industry Standards

• The use of a mix of RSUs and stock options is consistent with compensation structures at peer companies in the specialty materials sector.
• Vesting schedules of approximately one year for annual director grants align with typical corporate governance benchmarks for mid-cap industrial firms.

Corporate Governance

Stakeholder Impact

• Shareholders: Minor dilution from new equity issuance.
• Director: Increased alignment with company performance.

Next Steps

• Vesting of equity awards on May 13, 2027, or the day prior to the 2027 annual meeting.

Key Dates

Keywords

Aspen Aerogels, ASPN, Director Compensation, Equity Grant, Form 4, Insider Ownership